Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hunzelmann

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Annals of the Rheumatic Diseases|July 26, 2011
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centresJ Fransen, D Popa-Diaconu, R Hesselstrand, et al.
Annals of the Rheumatic Diseases|December 15, 2010
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesisP Dieudé, M Guedj, J Wipff, et al.
Zeitschrift Fur Rheumatologie|February 11, 2020
[Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]A Juche, E Siegert, U Mueller-Ladner, et al.
Arthritis and Rheumatism|September 8, 2011
Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotypeP Dieudé, M Bouaziz, M Guedj, et al.
Arthritis and Rheumatism|June 18, 2010
Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian populationJ Wipff, P Dieudé, M Guedj, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, M Geroldinger-Simić, A Kreuter, et al.
Arthritis and Rheumatism|December 17, 2010
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesisP Dieudé, M Guedj, M E Truchetet, et al.
Annals of the Rheumatic Diseases|October 10, 2009
BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in CaucasiansB Rueda, P Gourh, J Broen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2017
European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosisR Knobler, P Moinzadeh, N Hunzelmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 10, 2017
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, P Moinzadeh, N Hunzelmann, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Annals of the Rheumatic Diseases|July 26, 2011
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centresJ Fransen, D Popa-Diaconu, R Hesselstrand, et al.
Annals of the Rheumatic Diseases|December 15, 2010
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesisP Dieudé, M Guedj, J Wipff, et al.
Zeitschrift Fur Rheumatologie|February 11, 2020
[Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]A Juche, E Siegert, U Mueller-Ladner, et al.
Arthritis and Rheumatism|September 8, 2011
Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotypeP Dieudé, M Bouaziz, M Guedj, et al.
Arthritis and Rheumatism|June 18, 2010
Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian populationJ Wipff, P Dieudé, M Guedj, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, M Geroldinger-Simić, A Kreuter, et al.
Arthritis and Rheumatism|December 17, 2010
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesisP Dieudé, M Guedj, M E Truchetet, et al.
Annals of the Rheumatic Diseases|October 10, 2009
BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in CaucasiansB Rueda, P Gourh, J Broen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2017
European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosisR Knobler, P Moinzadeh, N Hunzelmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 10, 2017
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, P Moinzadeh, N Hunzelmann, et al.
Pageof 14